PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience

作者：Yinjun Lou, Ying Lu, Xingnong Ye, Yungui Wang, Yafang Ma, Cuihua Fan, Huifang Jiang, Jie Jin · 发表于：Hematological Oncology · 年份：2020 · DOI：10.1002/hon.2766 · 被引用次数：6 · 研究领域：Retinoids in leukemia and cellular processes、Acute Myeloid Leukemia Research、Acute Lymphoblastic Leukemia research

Figure S1 Figure S2 Supplementary Table 1 Comparing characteristics and PML-RARA reduction of APL patients with or without chemotherapy during induction. Supplementary Table 2 Summary of studies for newly diagnosed APL patients treated with arsenic plus ATRA-based chemotherapy-free regimens. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.